An investigation for investors in Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares over potential securities laws violations by Adverum Biotechnologies, Inc. was announced.

San Diego, CA -- (SBWire) -- 03/03/2020 --An investigation was announced concerning potential securities laws violations by Adverum Biotechnologies, Inc. in connection with certain financial statements.

Investors who purchased shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Adverum Biotechnologies, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Redwood City, CA based Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. ADVM-022 was intended to treat wet age-related macular degeneration ("wet AMD").

On September 12, 2019, Adverum Biotechnologies, Inc disclosed that patients taking the drug in the study suffered significant deterioration in their sight.

Shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) declined from $16.38 per share in July 2019 to as low as $5.10 per share in October 2019.

Those who purchased shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.